More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...
While some orthopedic and spine surgeons are divided on how medications used for weight loss, including Ozempic and Wegovy, will shape the field, it is undeniable that the drugs are playing an ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Swiss drugmaker Roche began a study last year of its experimental drug, RG6237, as a monotherapy in people with high body ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
In a potential setback for Rachel Reeves (pictured), official figures tare set to show inflation accelerated last month ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
CenterPoint Senior Vice President of External Affairs Mike Roeder said the new rate increase will initially start with a $7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback